BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36769068)

  • 1. Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Zheng Q; Jiang Z; Ni X; Yang S; Jiao P; Wu J; Xiong L; Yuan J; Wang J; Jian J; Wang L; Yang R; Chen Z; Liu X
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.
    Zheng Q; Yang R; Ni X; Yang S; Jiao P; Wu J; Xiong L; Wang J; Jian J; Jiang Z; Wang L; Chen Z; Liu X
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
    Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
    EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal of an automated tumor-stromal ratio assessment algorithm and a nomogram for prognosis in early-stage invasive breast cancer.
    Xu Q; Chen YY; Luo YH; Zheng JS; Lin ZH; Xiong B; Wang LW
    Cancer Med; 2023 Jan; 12(1):131-145. PubMed ID: 35689454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A classification based on tumor-stroma ratio and tumor budding for patients with muscle-invasive bladder cancer.
    Liu J; Li C; Huang K; Aldanakh A; Yang D; Wang J; Sun X; Song X
    Expert Rev Anticancer Ther; 2022 Mar; 22(3):323-330. PubMed ID: 34836489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer.
    Geessink OGF; Baidoshvili A; Klaase JM; Ehteshami Bejnordi B; Litjens GJS; van Pelt GW; Mesker WE; Nagtegaal ID; Ciompi F; van der Laak JAWM
    Cell Oncol (Dordr); 2019 Jun; 42(3):331-341. PubMed ID: 30825182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital image analysis provides robust tissue microenvironment-based prognosticators in patients with stage I-IV colorectal cancer.
    Jakab A; Patai ÁV; Micsik T
    Hum Pathol; 2022 Oct; 128():141-151. PubMed ID: 35820451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides.
    Zheng Q; Yang R; Ni X; Yang S; Xiong L; Yan D; Xia L; Yuan J; Wang J; Jiao P; Wu J; Hao Y; Wang J; Guo L; Jiang Z; Wang L; Chen Z; Liu X
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinoma.
    Liao H; Yuan J; Liu C; Zhang J; Yang Y; Liang H; Jiang S; Chen S; Li Y; Liu Y
    Insights Imaging; 2023 Dec; 14(1):223. PubMed ID: 38129708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
    Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
    EBioMedicine; 2024 Jun; 104():105152. PubMed ID: 38728838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain-specific transfer learning in the automated scoring of tumor-stroma ratio from histopathological images of colorectal cancer.
    Petäinen L; Väyrynen JP; Ruusuvuori P; Pölönen I; Äyrämö S; Kuopio T
    PLoS One; 2023; 18(5):e0286270. PubMed ID: 37235626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
    Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
    Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.
    van Wagensveld L; Walker C; Hahn K; Sanders J; Kruitwagen R; van der Aa M; Sonke G; Rottenberg S; Van de Vijver K; Janowczyk A; Horlings H
    Res Sq; 2023 Nov; ():. PubMed ID: 38014112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
    Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19
    Jiang Q; Fu Q; Chang Y; Liu Z; Zhang J; Xu L; Zhu Y; Wang Y; Zhang W; Xu J
    Cancer Immunol Immunother; 2019 Jan; 68(1):45-56. PubMed ID: 30259082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiperspective quantitative tumor-stroma ratio reveals histological areas associated with poor outcomes in oral squamous cell carcinoma.
    Wang S; Si Q; Wu Y; Sun Y; Zhang W; Huang X; Zeng T; Chen S; Yang X; Ni Y; Hu Q
    Cancer Med; 2023 Jun; 12(11):12161-12172. PubMed ID: 37184217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
    Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
    BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
    Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
    J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy
    Fan B; Zheng X; Wang Y; Hu X
    Pathol Oncol Res; 2023; 29():1611117. PubMed ID: 37082269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.